Literature DB >> 7044426

The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein.

J Keski-Oja, A Vaheri.   

Abstract

The effects of urokinase, the plasminogen activator of human urine, on the isolated substratum-attached pericellular matrices of cultured human lung fibroblasts were studied in serum-free conditions. Pericellular matrices were prepared from dense cultures of human lung fibroblasts after labelling of the cultures with radioactive glycine. Extraction of the cultures with sodium deoxycholate and hypotonic buffer gave a reproducible pattern of polypeptides when analyzed in polyacrylamide gels. The isolated pericellular matrix was subsequently exposed to affinity chromatography-purified urokinase. Urokinase affected a 66000-dalton protein but none of the other matrix polypeptides. The appearance of a 62000-dalton protein that remained attached to the matrix was seen concomitantly suggesting that it was derived from the 66000-dalton protein. The 66000-dalton protein is the first known cellular target for urokinase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044426     DOI: 10.1016/0167-4889(82)90005-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.

Authors:  B S Knudsen; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.

Authors:  J P Quigley; L I Gold; R Schwimmer; L M Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Binding of tissue plasminogen activator to cultured human endothelial cells.

Authors:  K A Hajjar; N M Hamel; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Importance of viability and attachment to an ascites tumor in the release of plasminogen activator.

Authors:  Q Dong; M Zhou; V Subbarao; C Ts'ao
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.

Authors:  Q Dong; M H Zhou; V Subbarao; C H Ts'ao
Journal:  Br J Exp Pathol       Date:  1988-10

8.  Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.

Authors:  B W Robinson
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

9.  Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.

Authors:  D L Eaton; J B Baker
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

10.  Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta.

Authors:  J Keski-Oja; F Blasi; E B Leof; H L Moses
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.